Francisca Ferrer Marin, Martha Sola Visner. 2021. Neonatal platelet physiology and implications for transfusion.. Platelets. Volumen 16. Páginas 1 - 9.

Julia Pe{ñ}as-mart{í}nez, Mar{í}a N Barrachina, Ernesto J Cuenca-zamora, Gin{é}s Luengo-gil, Susana Bel{é}n Bravo, Eva Caparr{ó}s-p{é}rez, Ra{ú}l Teruel-montoya, Jos{é} Eliseo-blanco, Vicente Vicente. 2021. Qualitative and Quantitative Comparison of Plasma Exosomes from Neonates and Adults. International journal of molecular sciences. Volumen 22(4). Páginas 1 - 21.

Francisca Ferrer-Marín, Francisca Ferrer-Mar{í}n, Ernesto José Cuenca-Zamora, Ernesto Jos{é} Cuenca-Zamora, Pedro Jesús Guijarro-Carrillo, Pedro Jes{ú}s Guijarro-Carrillo, Raúl Teruel-Montoya, Ra{ú}l Teruel-Montoya. 2021. Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms.. International journal of molecular sciences. Volumen 22. Páginas 1143 - 1143.

Irene Pastor-Gal{á}n, Manuel M {P{é}rez Encinas}, Juan Carlos Hern{á}ndez-Boluda, Marta Sobas, Juan-Gonzalo Correa, Alberto Alvarez-Larr{á}n, Aitor {Abuin Blanco}, Francisca Ferrer-Mar{í}n, Mar{í}a Soledad {Noya Pereira}, Jos{é} Mar{í}a Raya, Rosa Ayala, Marcio M Andrade-Campos, Patricia Velez, Alberto {{Á}lvarez Larr{á}n}, Manuel P{é}rez-Encinas, Krzysztof Lewandowski, Natalia Estrada, Szukalski Łukasz, Valent{í}n Garc{í}a-Guti{é}rrez, Juan Carlos {Hern{á}ndez Boluda}, Mar{í}a Laura Fox, Angel Payer, Ana Kerguelen, Aleksandra Gołos, Beatriz Cuevas, Mercedes {Gasior Kabat}, Mar{í}a Antonia Dur{á}n, Elena {Magro Mazo}, Mar{í}a Jos{é} Ram{í}rez, Anna Czyż, Mar{í}a Teresa G{ó}mez-Casares, Alejandro {Mart{í}n Mart{í}n}, Mar{í}a Isabel Mata-V{á}zquez, Beatriz {Bellosillo Paricio}, Elvira Mora, Celsa {Quinteiro Garc{í}a}, Clara Mart{í}nez-Valverde, Jes{ú}s Mar{í}a {Gonz{á}lez Mart{í}n}, Elisa Arbelo, Ruth Stuckey, Anna Angona, Elena Magro, Mar{í}a Luisa Antelo, Nieves Somolinos, Francisco Cervantes. 2020. The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study.. European journal of haematology. Volumen 106. Páginas 371 - 379.

S.J. Rios, L. Martínez-Montesinos, L. Mart{í}nez-Montesinos, C. Aroca, R. Teruel-Montoya, F. Ferrer-Marín, F. Ferrer-Mar{í}n. 2020. Successful ovarian stimulation and pregnancy in an infertile woman with chronic myeloid leukemia. Journal of Assisted Reproduction and Genetics. Volumen 37. Páginas 2473 - 2476.

Alberto Alvarez-Larr{á}n, Arturo Pereira, Marta Magaz, Juan Carlos Hern{á}ndez-Boluda, Marta Garrote, Beatriz Cuevas, Francisca Ferrer-Mar{í}n, M Teresa G{ó}mez-Casares, Valent{í}n Garc{í}a-Guti{é}rrez, M Isabel Mata-V{á}zquez, Fanny Turon, Virginia Hernandez-Gea, Eduardo Arellano-Rodrigo, Francisco Cervantes, Juan Carlos Garc{í}a-Pag{á}n. 2020. Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis.. Annals of hematology. Volumen 99. Páginas 791 - 798.

F. Ferrer-Marín, F Ferrer-Mar{í}n, A.B. Arroyo, A B Arroyo, B. Bellosillo, B Bellosillo, E.J. Cuenca, E J Cuenca, L. Zamora, L Zamora, J.M. Hernández-Rivas, J M Hern{á}ndez-Rivas, J.C. Hernández-Boluda, J C Hern{á}ndez-Boluda, C. Fernandez-Rodriguez, C Fernandez-Rodriguez, E. Luño, E Lu{ñ}o, C. García Hernandez, C {Garc{í}a Hernandez}, A. Kerguelen, A Kerguelen, D.V. Fiallo-Suárez, D V Fiallo-Su{á}rez, M.T. Gómez-Casares, M T G{ó}mez-Casares, R. Ayala, R Ayala, P. Vélez, P V{é}lez, C. Boqué, C Boqu{é}, V. García-Gutierrez, V Garc{í}a-Gutierrez, B. Arrizabalaga, B Arrizabalaga, N. Estrada, N Estrada, R. Cifuentes, R Cifuentes, I. Arcas, I Arcas, A.M. de los Reyes-García, A M {de Los Reyes-Garc{í}a}, C. Besses, C Besses, V. Vicente, V Vicente, A. Alvarez-Larrán, A Alvarez-Larr{á}n, R. Teruel-Montoya, R Teruel-Montoya, R. González-Conejero, R Gonz{á}lez-Conejero, C. Martínez, C Mart{í}nez, GEMFIN Group. 2020. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk.. Leukemia. Volumen 34. Páginas 2648 - 59..

V. Palma-Barqueros, Ver{ó}nica Palma-Barqueros, J.M. Torregrosa, Jos{é} Miguel Torregrosa, E. Caparrós-Pérez, Eva Caparr{ó}s-P{é}rez, N. Mota-Pérez, Nerea Mota-P{é}rez, N. Bohdan, Natalia Bohdan, M.D.C. Llanos, Mar{í}a Del Carmen Llanos, A.J. Begonja, Antonija Jurak Begonja, M. Sola-Visner, Martha Sola-Visner, V. Vicente, Vicente Vicente, R. Teruel-Montoya, Ra{ú}l Teruel-Montoya, J. Rivera, Jos{é} Rivera, F. Ferrer-Marín, Francisca Ferrer-Mar{í}n. 2020. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.. Neonatology. Volumen 117. Páginas 15 - 23.

Ernesto José Cuenca Zamora, Ernesto José Cuenca-Zamora, Francisca Ferrer Marín, Francisca Ferrer-Marín, José Rivera, Raúl Teruel Montoya, Raúl Teruel-Montoya. 2019. Tubulin in Platelets: When the Shape Matters. International Journal of Molecular Sciences. Volumen 20. Páginas 3484 - 3484.

RM Patel, CD Josephson, N Shenvi, A Maheshwari, KA Easly, S Stowel, M Sola-Visner, F Ferrer-Marin. 2019. Platelet transfusions and mortality in necrotizing enterocolitis.. Transfusion. Volumen 59. Páginas 981 - 988.

Francisca Ferrer Marin, A Alvarez-Larran, D Martínez, L Arenillas, A Rubio, E Arellano-Rodrigo, JC Hernández Boluda, N Papaleo, G Caballero, C Martínez, F Ferrer-Marín, MI Mata, M Pérez-Encinas, MA Durán, JM Alonso, G Carreño-Tarragona, S Noya, E Magro, R Pérez, M López-Guerra, I Pastor-Galán, F Cervantes, C Besses, L Colomo, M Rozman. 2018. Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes.. Journal of Clinical Pathology. Volumen 71. Páginas 975 - 980.

Francisca Ferrer Marin, AT Hardy, V Palma-Varqueros, SK Watson, JD Malcor, JA Eble, EE Gardiner, JE Blanco, R Guijarro-Campillo, JL Delgado, ML Lozano, Raul Teruel-Montoya, V Vicente, SP Watson, J Rivera, Francsica Ferrer-Marín. 2018. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia. Thrombosis and Haemostasis. Volumen 118. Páginas 1009 - 1020.

Alexander T Hardy, AT Hardy, Verónica Palma Barqueros, V Palma-Varqueros, Stephanie K Watson, SK Watson, Raúl Teruel Montoya, JD Malcor, Jean-Daniel Malcor, JA Eble, Johannes A Eble, EE Gardiner, Elizabeth E Gardiner, JE Blanco, José E Blanco, R Guijarro-Campillo, Rafael Guijarro Campillo, JL Delgado, Juan L Delgado, ML Lozano, María L Lozano, Raul Teruel-Montoya, Vicente Vicente, V Vicente, Steve P Watson, SP Watson, José Rivera, J Rivera, Francisca Ferrer Marín, Francsica Ferrer-Marín. 2018. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia.. Thrombosis and Haemostasis. Volumen 118. Páginas 1009 - 1020.

Francisca Ferrer Marin, Juan-Carlos Hernández Boluda, Juan-Gonzalo Correa, Alberto Alvarez Larrán, José-María Raya, Joaquín Martínez López, Patricia Velez, Manuel Pérez Encinas, Natalia Estrada, Valentín García Gutiérrez, María-Laura Fox, Elisa Luño, Ana Kerguelen, Beatriz Cuevas, María-Antonia Durán, María-José Ramírez, Maite Gómez Casares, María-Isabel Mata Vázquez, Anabel Regadera, Arturo Pereira, Francisco Cervantes. 2018. Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia.. British journal of haematology. Volumen 181. Páginas 397 - 400.

Francisca Ferrer Marin, JC Hernández-Boluda, A Pereira, JG Correa, A Alvarez-Larrán, F Ferrer-Marín, JM Raya, J Martínez-López, P Velez, N Pérez-Encinas, N Estrada, V García-Gutiérrez, ML Fox, A Payer, A Kerguelen, B Cuevas, MA Durán, MJ Ramírez, M Gómez-Casares, IM Mata-Vázquez, E Mora, M Gómez, F Cervantes. 2018. Prognostic risk models for transplant decision-making in myelofibrosis. Annals of hematology. Volumen 97. Páginas 813 - 820.

Francisca Ferrer Marin, Hermógenes Fernández Muñoz, Cristina Castilla Llorente, Eva M Plaza, Cristina Martínez Millán, Inmaculada Heras, Pastora Iniesta, María L Amigo, María J Candela, María L Lozano, Vicente Vicente, José Rivera. 2018. Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution.. Blood transfusion. Volumen 16. Páginas 273 - 278.

Francisca Ferrer Marin, Teresa Sevivas, José María Bastida, David S Paul, Eva Caparros, Verónica Palma Barqueros, Margarida Coucelo, Dalila Marques, José Ramón González Porras, Vicente Vicente, Jesús María Hernández Rivas, Steve P Watson, María Luisa Lozano, Wolfgang Bergmeier, José Rivera. 2018. Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis.. Platelets. Volumen Aug 1. Páginas 1 - 4.

Francisca Ferrer Marin, J-C Hernández Boluda, A Pereira, J-G Correa, A Alvarez Larrán, F Ferrer Marín, J-M Raya, J Martínez López, M Pérez Encinas, N Estrada, P Velez, M-L Fox, V García Gutiérrez, A Payer, A Kerguelen, B Cuevas, M-A Durán, M-J Ramírez, M-T Gómez Casares, M-I Mata Vázquez, E Mora, C Martínez Valverde, M Gómez, F Cervantes. 2018. Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis.. Leukemia. Volumen 32. Páginas 553 - 555.

Francisca Ferrer Marin, V Lorenz, H Ramsey, ZJ Liu, J Jr Italiano, K Hoffmeister, S Bihorel, D Mager, Z Hu, WB Slayton, BT Kile, Martha Sola_Visner, Francisca Ferrer-Marín. 2017. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.. Thrombosis and Haemostasis. Volumen 117. Páginas 2322 - 2333.

Francisca Ferrer Marin, Eva Caparrós Pérez, Raúl Teruel Montoya, Verónica Palma Barquero, Raúl Teruel Montoya, José M Torregrosa, José E Blanco, Juan L Delgado, María Luisa Lozano, Vicente Vicente, Martha Sola Visner, José Rivera, Constantino Martínez, Francisca Ferrer Marín. 2017. Down Regulation of the Munc18b-syntaxin-11 Complex and betha1-tubulin Impairs Secretion and Spreading in Neonatal Platelets.. Thrombosis and Haemostasis. Volumen 117. Páginas 2079 - 2091.

Francisca Ferrer Marin, A Alvarez-Larrán, A Senín, C Fernández-Rodríguez, A Pereira, E Arellano-Rodrigo, M Gómez, F Ferrer-Marin, J Martínez-López, L Camacho, D Colomer, A Angona, B Navarro, F Cervantes, C Besses, B Bellosillo, JC Hernández-Boluda. 2017. Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia.. British journal of haematology. Volumen 178. Páginas 764 - 771.

Francisca Ferrer Marin, Juan-Carlos Hernández Boluda, Juan-Gonzalo Correa, Regina García Delgado, Joaquín Martínez López, Alberto Alvarez Larrán, María-Laura Fox, Valentín García Gutiérrez, Manuel Pérez Encinas, María-Isabel Mata Vázquez, José-María Raya, Natalia Estrada, Silvia García, Ana Kerguelen, María-Antonia Durán, Manuel Albors, Francisco Cervantes. 2017. Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis.. European journal of haematology. Volumen 98. Páginas 407 - 414.

Francisca Ferrer Marin, Alberto Alvarez Larrán, Manuel Pérez Encinas, Juan Carlos Hernández Boluda, María José Ramírez, Joaquín Martínez López, Elena Magro, Yasmina Cruz, María Isabel Mata, Pilar Aragües, María Laura Fox, Beatriz Cuevas, Sara Montesdeoca, José Angel Hernández Rivas, Valentín García Gutiérrez, María Teresa Gómez Casares, Juan Luis Steegmann, María Antonia Durán, Montse Gómez, Ana Kerguelen, Abelardo Bárez, Mari Carmen García, Concepción Boqué, José María Raya, Clara Martínez, Manuel Albors, Francesc García, Carmen Burgaleta, Carlos Besses. 2017. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.. Haematologica. Volumen 102. Páginas 103 - 109.

Francisca Ferrer Marin, Santiago Osorio, Vicente Escudero Vilaplana, Laura Reguilón Gallego, Ignacio Gómez Centurión, José Luis Díez. 2017. Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline.. Journal of oncology pharmacy practice. Volumen 1. Páginas 1078155217735689 - 1078155217735689.

F Cervantes, JG Correa, I Pérez, V García-Gutiérrez, S Redondo, D Colomer, A Jiménez-Velasco, JL Steegmann, F Sánchez-Guijo, F Ferrer-Marín, A Pereira, S Osorio. 2017. Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response. Annals of Hematology. Volumen 96. Páginas 81 - 85.

Francisca Ferrer Marin, María Luisa Lozano, Aaron Cook, José María Bastida, David S Paul, Gemma Iruin, Ana Rosa Cid, Rosa Adan Pedroso, José Ramón González Porras, Jesús María Hernández Rivas, Sarah J Fletcher, Ben Johnson, Neil Morgan, Vicente Vicente, John Sondek, Steve P Watson, Wolfgang Bergmeier, José Rivera. 2016. Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction.. Blood. Volumen 128. Páginas 1282 - 1289.

Francisca Ferrer Marin, Alberto Alvarez Larrán, Arturo Pereira, Paola Guglielmelli, Juan Carlos Hernández Boluda, Eduardo Arellano Rodrigo, Alimam Samah, Martin Griesshammer, Ana Kerguelen, Bjorn Andreasson, Carmen Burgaleta, Jiri Schwarz, Valentín García Gutiérrez, Rosa Ayala, Pere Barba, María Teresa Gómez Casares, Chiara Paoli, Beatrice Drexler, Sonja Zweegman, Mary F McMullin, Jan Samuelsson, Claire Harrison, Francisco Cervantes, Alessandro M Vannucchi, Carlos Besses. 2016. Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.. Haematologica. Volumen 101. Páginas 926 - 931.

Francisca Ferrer Marin, Alberto Alvarez Larrán, Ana Kerguelen, Juan C Hernández Boluda, Manuel Pérez Encinas, Abelardo Bárez, Joaquín Martínez López, Beatriz Cuevas, M Isabel Mata, Valentín García Gutiérrez, Pilar Aragües, Sara Montesdeoca, Carmen Burgaleta, Gonzalo Caballero, J Angel Hernández Rivas, M Antonia Durán, M Teresa Gómez Casares, Carles Besses. 2016. Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera.. British journal of haematology. Volumen 172. Páginas 786 - 793.

Francisca Ferrer Marin, Jose M Torregrosa, María L Lozano, Maria J Moreno, Constantino Martinez, Ana I Anton, José Rivera, Vicente Vicente. 2016. Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation.. British journal of haematology. Volumen 172. Páginas 813 - 815.

Francisca Ferrer Marin, Montse Gómez, Vicent Guillem, Arturo Pereira, Alberto Álvarez Larrán, Ana Kerguelen, Natàlia Estrada, Joaquín Martínez López, Anna Angona, Paula Amat, Blanca Navarro, Carles Besses, Juan-Carlos Hernández Boluda. 2016. Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera.. European journal of haematology. Volumen 96. Páginas 285 - 290.

Francisca Ferrer Marin, Juan-Carlos Hernández Boluda, Alejandra Martínez Trillos, Valentín García Gutiérrez, Blanca Xicoy, Alberto Alvarez Larrán, Ana Kerguelen, Pere Barba, Montse Gómez, Juan-Carlos Herrera, Juan-Gonzalo Correa, Francisco Cervantes. 2016. Long-term results of prednisone treatment for the anemia of myelofibrosis.. Leukemia & lymphoma. Volumen 57. Páginas 120 - 124.

Francisca Ferrer Marin, Jose Miguel Torregrosa, Gloria Soler, Shirley Cancio. 2015. [Concurrent lymphoid and Philadelphia chromosome-negative myeloproliferative neoplasms].. Medicina cli?nica. Volumen 145. Páginas 318 - 319.

Francisca Ferrer Marin, Zhi-Jian Liu, James B Bussel, Madhavi Lakkaraja, Cedric Ghevaert, Henry A Feldman, Janice G McFarland, Chaitanya Chavda, Martha Sola Visner. 2015. Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies.. Blood. Volumen 126. Páginas 1234 - 1236.

Francisca Ferrer Marin, I M Sánchez Guiu, I Martínez Martinez, C Martínez, J Navarro Fernandez, F García Candel, F Ferrer Marín, V Vicente, S P Watson, R K Andrews, E E Gardiner, M L Lozano, J Rivera. 2015. An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets.. Thrombosis and haemostasis. Volumen 114. Páginas 313 - 324.

Francisca Ferrer Marin, Juan-Carlos Hernández Boluda, Eduardo Arellano Rodrigo, Francisco Cervantes, Alberto Alvarez Larrán, Montse Gómez, Pere Barba, María-Isabel Mata, José-Ramón González Porras, Valentín García Gutiérrez, Elena Magro, Melania Moreno, Ana Kerguelen, Manuel Pérez Encinas, Natàlia Estrada, Rosa Ayala, Carles Besses, Arturo Pereira. 2015. Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia.. Annals of hematology. Volumen 94. Páginas 911 - 918.

Francisca Ferrer Marin, G Soler, A Bernal Vicente, A I Antón, J M Torregrosa, E Caparrós Pérez, I Sánchez Serrano, A Martínez Pérez, B Sánchez Vega, V Vicente, F Ferrer Marin. 2015. The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms.. Annals of hematology. Volumen 94. Páginas 789 - 794.

Francisca Ferrer Marin, Constantino Martínez, Ana Isabel Antón, Agustina Bernal, María Luisa Lozano, Javier Corral, Juan Antonio Iniesta, Vicente Vicente, José Rivera. 2015. Evaluation of Novel Platelet Polymorphisms in Stroke. Dichotomic Effect of rs5443 in GNB3.. Journal of clinical neurology (Seoul, Korea). Volumen 11. Páginas 102 - 103.

Francisca Ferrer Marin, Alberto Alvarez Larrán, Luz Martínez Avilés, Juan Carlos Hernández Boluda, María Luisa Antelo, Carmen Burgaleta, M Isabel Mata, Blanca Xicoy, Alejandra Martínez Trillos, M Teresa Gómez Casares, M Antonia Durán, Bárbara Marcote, Agueda Ancochea, Alicia Senín, Anna Angona, Montse Gómez, Vicente Vicente, Francisco Cervantes, Beatriz Bellosillo, Carles Besses. 2014. Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.. Annals of hematology. Volumen 93. Páginas 2037 - 2043.

Francisca Ferrer Marin, A Gómez Simón, E M Plaza, J M Torregrosa, F Ferrer Marín, I Sánchez Guiu, V Vicente, M L Lozano, J Rivera. 2014. Evaluation of two-step haemoglobin screening with HemoCue for blood donor qualification in mobile collection sites.. Vox sanguinis. Volumen 107. Páginas 343 - 350.

Francisca Ferrer Marin, Juan-Carlos Hernández Boluda, Arturo Pereira, Montse Gómez, Concepción Boqué, José-María Raya, Valentín García Gutiérrez, Ana Kerguelen, Blanca Xicoy, Pere Barba, Jesús Martínez, Elisa Luño, Alberto Alvarez Larrán, Joaquín Martínez López, Elisa Arbelo, Carles Besses. 2014. The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis.. Haematologica. Volumen 99. Páginas 55 - 57.

Francisca Ferrer Marin, F Ferrer Marin, R Gutti, Z-J Liu, M Sola Visner. 2014. MiR-9 contributes to the developmental differences in CXCR-4 expression in human megakaryocytes.. Journal of thrombosis and haemostasis. Volumen 12. Páginas 282 - 285.

Francisca Ferrer Marin, Simon Stanworth, Cassandra Josephson, Martha Sola Visner. 2013. Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice.. Transfusion. Volumen 53. Páginas 2814 - 2821.

Francisca Ferrer Marin, Juan Carlos Hernández Boluda, Arturo Pereira, Francisco Cervantes, Montse Gómez, Eduardo Arellano Rodrigo, Alberto Alvarez Larrán, Ana Kerguelen, José Antonio Márquez, María Luisa Antelo, Carles Besses. 2013. Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide.. Annals of hematology. Volumen 92. Páginas 771 - 775.

Francisca Ferrer Marin, Beatriz Bellosillo, Luz Martínez Avilés, Gloria Soler, Pablo Carbonell, Ginés Luengo Gil, Eva Caparrós, José M Torregrosa, Carlos Besses, Vicente Vicente. 2013. Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing.. Journal of hematology & oncology. Volumen 6. Páginas 68 - 68.

Francisca Ferrer Marin, Alberto Alvarez Larrán, Arturo Pereira, Francisco Cervantes, Eduardo Arellano Rodrigo, Juan-Carlos Hernández Boluda, Anna Angona, Montse Gómez, Begoña Muiña, Helga Guillén, Anabel Teruel, Beatriz Bellosillo, Carmen Burgaleta, Vicente Vicente, Carles Besses. 2012. Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera.. Blood. Volumen 119. Páginas 1363 - 1369.

Francisca Ferrer Marin. 2012. Leukemic transformation in hematologic patients receiving tumor necrosis factor-alpha inhibitors: a case report and literature review. Clinical Drug Investigation. Volumen 32. Páginas 423 - 426.

Francisca Ferrer Marin, F Ferrer Marin, C Chavda, M Lampa, A D Michelson, A L Frelinger, M Sola Visner. 2011. Effects of in vitro adult platelet transfusions on neonatal hemostasis.. Journal of thrombosis and haemostasis. Volumen 9. Páginas 1020 - 1028.

Francisca Ferrer Marin, Zhi-Jian Liu, Joseph Italiano, Ravi Gutti, Matthew Bailey, Brandon Poterjoy, Lisa Rimsza, Martha Sola Visner. 2011. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes.. Blood. Volumen 117. Páginas 4106 - 4117.

Francisca Ferrer Marin, Alexandre Hertig. 2011. Correction of anaemia on dialysis: did we forget physiology?. Nephrology, dialysis, transplantation. Volumen 26. Páginas 1120 - 1122.

Francisca Ferrer Marin, H Sallmon, R K Gutti, F Ferrer Marin, Z-J Liu, M C Sola Visner. 2010. Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?. Journal of Perinatology. Volumen 30. Páginas 765 - 769.

Francisca Ferrer Marin, Zhi-Jian Liu, Ravi Gutti, Martha Sola Visner. 2010. Neonatal thrombocytopenia and megakaryocytopoiesis.. Seminars in hematology. Volumen 47. Páginas 281 - 288.

Francisca Ferrer Marin, María José Moreno, María Luisa Lozano, Francisca Ferrer, Beatriz Bellosillo, Carlos Besses, Vicente Vicente, Constantino Martínez. 2009. ABO blood group does not increase the risk of thrombosis in Philadelphia-negative myeloproliferative disorders.. Blood coagulation & fibrinolysis. Volumen 20. Páginas 390 - 392.

Francisca Ferrer Marin, Manuel Muro, Jose Rivera, Carmen Botella, Jose A Campillo, Francisca Ferrer, María R Alvarez López. 2008. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report.. Transfusion and apheresis science. Volumen 38. Páginas 209 - 212.

Francisca Ferrer Marin, David Hernández Espinosa, Antonia Miñano, Constantino Martínez, Adriana Ordoñez, Elena Pérez Ceballos, Felipe de Arriba, Rubén A Mota, Francisca Ferrer, Marcos González, Vicente Vicente, Javier Corral. 2008. Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin.. Laboratory investigation. Volumen 88. Páginas 306 - 317.

Francisca Ferrer Marin, R González Conejero, J Corral, V Roldán, F Ferrer, I Sánchez Serrano, J J Sánchez Blanco, F Marín, V Vicente. 2007. The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol.. Journal of thrombosis and haemostasis. Volumen 5. Páginas 1701 - 1706.

Francisca Ferrer Marin, M A Medranda Gómez, P Paricio Núñez, A Tovar Martínez, F Ferrer Marín, P Gónzalez Martínez, M J García Puche. 2005. CA 19.9 and pulmonary fibrosis.. Revista espan?ola de enfermedades digestivas. Volumen 97. Páginas 843 - 844.

Francisca Ferrer Marin, Francisca Ferrer, Margarita Cámara, Francisco Ortuño. 2004. Peripheral blood mitosis in association with Mycoplasma pneumoniae infection.. American journal of hematology. Volumen 76. Páginas 413 - 414.

Francisca Ferrer Marin, F Ferrer, J Rivera, M L Lozano, J Corral, V V García. 2001. Effect of cold-storage in the accumulation of bioreactive substances in platelet concentrates treated with second messenger effects.. Haematologica. Volumen 86. Páginas 530 - 536.

Francisca Ferrer Marin, F Ferrer, J Rivera, J Corral, R Gonzalez Conejero, M L Lozano, V Vicente. 2000. Evaluation of pooled platelet concentrates using prestorage versus poststorage WBC reduction: impact of filtration timing.. Transfusion. Volumen 40. Páginas 781 - 788.

Francisca Ferrer Marin, F Ferrer, J Rivera, J Corral, R González Conejero, V Vicente. 2000. Evaluation of leukocyte-depleted platelet concentrates obtained by in-line filtration.. Vox sanguinis. Volumen 78. Páginas 235 - 241.

Francisca Ferrer Marin, J Corral, I Zuazu Jausoro, J Rivera, R González Conejero, F Ferrer, V Vicente. 1999. Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family.. British journal of haematology. Volumen 105. Páginas 560 - 563.

Francisca Ferrer Marin, F Ferrer, J M Moraleda, V Vicente. 1999. Antithrombotic therapy after coronary-artery stenting.. The New England journal of medicine. Volumen 340. Páginas 1365 - 1365.

Francisca Ferrer Marin, J Rivera, M L Lozano, J Corral, J Connor, R Gónzález Conejero, F Ferrer, L Currie, V Vicente. 1999. Quality assessment of platelet concentrates supplemented with second-messenger effectors.. Transfusion. Volumen 39. Páginas 135 - 143.

Francisca Ferrer Marin. 1998. Aplastic anemia induced by Ticlopidine after the placement of coronary-artery stents. Therapeutic role of G-CSF. Clinical Drug Investigation. Volumen 15. Páginas 261 - 262.

Francisca Ferrer Marin. 1998. “Aspergilosis cutánea por Aspergillus Flavus”. Medicina Clinica. Volumen 110. Páginas 760 - 760.

Francisca Ferrer Marin, F Ferrer, J M Moraleda, M C Toldos, I Heras, V Vicente. 1997. Disseminated aspergillosis after mobilization with intensive chemotherapy prior to autologous stem-cell transplant in chronic myeloid leukemia.. American journal of hematology. Volumen 54. Páginas 170 - 171.

Francisca Ferrer Marin, F Ferrer, M J Candela, C Garcia, L Martinez, J Rivera, V Vicente. 1997. A comparative study of two third-generation anti-hepatitis C virus ELISAs.. Haematologica. Volumen 82. Páginas 690 - 691.

Francisca Ferrer Marin, F Ortuño, F Ferrer, M L Lozano, I Heras, J M Moraleda, V Vicente. 1997. Differences in phycoerythrin- or fluorescein-isothiocyanate conjugated 8G12 on CD34+ cell evaluation.. Haematologica. Volumen 82. Páginas 334 - 335.

Francisca Ferrer Marin, F de Arriba, I Heras, M del Carmen Garcia, J M Moraleda, C Funes, F Ferrer, V Vicente. 1996. [Economic costs of autotransplantation of hematopoietic progenitors].. Medicina cli?nica. Volumen 106. Páginas 329 - 332.

Francisca Ferrer Marin. 2018. Neoplasias Mieloproliferativas y sistema hemostático. ARAN. Páginas 131 - 136.

Francisca Ferrer Marin, Martha Sola Visner. 2010. Descubriendo De Las Necesidades Del Recién Nacido Con Trombocitopenia. Sola, A. Edit. EDIMED. Páginas 600 - 618.

Francisca Ferrer Marin. 2007. Actualización del Tratamiento de la Trombocitemia Esencial. C Besses, L Hernández, V Vicente. (eds.) Edit. Acción Médica. Páginas 81 - 93.

Francisca Ferrer Marin, Francisca Ferrer. 1998. Náuseas y vómitos. En: Ribera, J.M. (Dir.).M-28411. Ergon. Barcelona,. Páginas 77 - 92.

Francisca Ferrer Marin. 1997. Gammapatías Monoclonales. Edit. Luzán 5. Páginas 1261 - 1268.

Francisca Ferrer Marin. 1997. Hemoterapia. Edit. Luzán 5. Páginas 1314 - 1318.

Francisca Ferrer Marin. 1997. Síndromes Linfoproliferativos. Edit. Luzán 5. Páginas 1247 - 1253.

Francisca Ferrer Marin. 1997. Síndromes Linfoproliferativos Crónicos con expresión leucémica. Edit. Luzán 5. Páginas 1255 - 1260.

Francisca Ferrer Marin. 1997. Terapia Antineoplásica y Trasplante de Médula Ósea. Edit. Luzán. Páginas 1277 - 1286.

Ana Triguero, Alexandra Pedraza, Manuel Perez-Encinas, Mar{í}a Isabel Mata-Vazquez, Patricia V{é}lez, Laura Fox, Montse Gomez-Calafat, Regina Garcia-Delgado, Mercedes Gasior, Francisca Ferrer-Marin, Valent{í}n Garcia-Gutierrez, Anna Angona, Mar{í}a Teresa Gomez-Casares, Beatriz Cuevas, Clara Mart{í}nez, Ra{ú}l P{é}rez, Jos{é} Mar{í}a Raya, Luc{í}a Guerrero, Ilda Murillo, Beatriz Bellosillo, Juan Carlos Hernandez-Boluda, Cristina Sanz, Alberto Alvarez-Larran. 2022. Correction to: Low‑risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.. Annals of hematology. Volumen 101. Páginas 2819 - 2820.

Juan-Carlos Hern{á}ndez-Boluda, Irene Pastor-Gal{á}n, Eduardo Arellano-Rodrigo, Jos{é}-Mar{í}a Raya, Manuel P{é}rez-Encinas, Rosa Ayala, Francisca Ferrer-Mar{í}n, Patricia Velez, Elvira Mora, Mar{í}a-Laura Fox, Jes{ú}s-Mar{í}a Hern{á}ndez-Rivas, Blanca Xicoy, Mar{í}a-Isabel Mata-V{á}zquez, Mar{í}a Garc{í}a-Fortes, Ra{ú}l P{é}rez-L{ó}pez, Anna Angona, Beatriz Cuevas, Alicia Sen{í}n, Mar{í}a-Jos{é} Ram{í}rez, Angel Ram{í}rez-Payer, Mar{í}a-Teresa G{ó}mez-Casares, Clara Mart{í}nez-Valverde, Elena Magro, Juan-Luis Steegmann, Mar{í}a-Antonia Dur{á}n, Carmen Garc{í}a-Hern{á}ndez, Mercedes Gasior, Sonia Gonz{á}lez de Villambrosia, Alberto Alvarez-Larr{á}n, Arturo Pereira. 2022. Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.. British journal of haematology. Volumen 199. Páginas 529 - 538.

Ana Triguero, Alexandra Pedraza, Manuel P{é}rez-Encinas, Mar{í}a Isabel Mata-V{á}zquez, Patricia V{é}lez, Laura Fox, Montse G{ó}mez-Calafat, Regina Garc{í}a-Delgado, Mercedes Gasior, Francisca Ferrer-Mar{í}n, Valent{í}n Garc{í}a-Guti{é}rrez, Anna Angona, Mar{í}a Teresa G{ó}mez-Casares, Beatriz Cuevas, Clara Mart{í}nez, Ra{ú}l P{é}rez, Jos{é} Mar{í}a Raya, Luc{í}a Guerrero, Ilda Murillo, Beatriz Bellosillo, Juan Carlos Hern{á}ndez-Boluda, Cristina Sanz, Alberto {Á}lvarez-Larr{á}n. 2022. Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.. Annals of hematology. Volumen 101. Páginas 2231 - 2239.

Ricardo S{á}nchez, Sara Dorado, Yanira Ru{í}z-Heredia, Alejandro Mart{í}n-Mu{ñ}oz, Juan Manuel Rosa-Rosa, Jordi Ribera, Olga Garc{í}a, Ana Jimenez-Ubieto, Gonzalo Carre{ñ}o-Tarragona, Mar{í}a Linares, Laura Rufi{á}n, Alexandra Ju{á}rez, Jaime Carrillo, Mar{í}a Jos{é} Espino, Mercedes C{á}ceres, Sara Exp{ó}sito, Beatriz Cuevas, Ra{ú}l Vanegas, Luis Felipe Casado, Anna Torrent, Lurdes Zamora, Santiago Mercadal, Rosa Coll, Marta Cervera, Mireia Morgades, Jos{é} {Á}ngel Hern{á}ndez-Rivas, Pilar Bravo, Cristina Ser{í}, Eduardo Anguita, Eva Barrag{á}n, Claudia Sargas, Francisca Ferrer-Mar{í}n, Jorge S{á}nchez-Calero, Juli{á}n Sevilla, Elena Ru{í}z, Luc{í}a Villal{ó}n, Mar{í}a {Del Mar Herr{á}ez}, Rosal{í}a Riaza, Elena Magro, Juan Luis Steegman, Chongwu Wang, Paula de Toledo, Valent{í}n Garc{í}a-Guti{é}rrez, Rosa Ayala, Josep-Maria Ribera, Santiago Barrio, Joaqu{í}n Mart{í}nez-L{ó}pez. 2022. Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.. Scientific reports. Volumen 12. Páginas 13057 - 13057.

Alberto Alvarez-Larr{á}n, Marta Garrote, Francisca Ferrer-Mar{í}n, Manuel P{é}rez-Encinas, M Isabel Mata-Vazquez, Beatriz Bellosillo, Eduardo Arellano-Rodrigo, Montse G{ó}mez, Regina Garc{í}a, Valent{í}n Garc{í}a-Guti{é}rrez, Mercedes Gasior, Beatriz Cuevas, Anna Angona, Mar{í}a Teresa G{ó}mez-Casares, Clara M Mart{í}nez, Elena Magro, Rosa Ayala, Rafael {Del Orbe-Barreto}, Ra{ú}l P{é}rez-L{ó}pez, Maria Laura Fox, Jos{é}-Mar{í}a Raya, Luc{í}a Guerrero, Carmen Garc{í}a-Hern{á}ndez, Gonzalo Caballero, Ilda Murillo, Blanca Xicoy, M Jos{é} Ram{í}rez, Gonzalo Carre{ñ}o-Tarragona, Juan Carlos Hern{á}ndez-Boluda, Arturo Pereira. 2022. Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.. Cancer. Volumen 128. Páginas 2441 - 2448.

Francisca Ferrer Marin, Emmanuel Gimenez, Carles Besses, Concepcion Boque, Patricia Velez, Ana Kerguelen, Francisco Cervantes, Manuel Perez Encinas, Mercedes Rodriguez, Juan Diego Gonzalez, Reyes Calzada, Juan Carlos Hernandez Boluda. 2014. Indirect and non-medical economic burden, quality-of-life, and disabilities of the myelofibrosis disease in Spain.. Journal of medical economics. Volumen 17. Páginas 435 - 441.

Francisca Ferrer Marin. 2009. Parasitemia with plasmodium falciparum in a patient after cardiac surgery in a non-endemic country. Enfermedades Emergentes. Volumen 11. Páginas 9 - 12.

Francisca Ferrer Marin. 2006. Linfoma pulmonar primario de bajo grado no BALT. A propósito de un caso y revisión de la literatura. Oncología. Volumen 29. Páginas 40 - 44.

FFIS-CNT-2020. VWF levels & NETosis: biomarkers of thrombotic risk in patients with chronic myeloid leukemia (CML) treated with Ponatinib.. Incyte Corporation. (2020-2023)

Role for the TLR/IRAK/NF-kB inflammation pahway in the development of myeloproliferative phenotype.. Cty Biophama Corp. (2020-2022)

Role for the TLR/IRAK/NF-κB inflammation pathway in the development of myeloproliferative phenotype. CTI BioPharma (0101010101). (2019-2020)

PAPEL DE LAS VARIANTES GENÉTICAS FUNCIONALES DEL MIR‐146a‐5P EN EL RIESGO Y SEVERIDAD DE LA MIELOFIBROSIS. Novartis Farmacéutica, S.A. (NCC Study Code: CINC424AES05T). (2014-2016)

CB15/00055: El sistema Hemostático: Fuente y diana de enfermedades raras.. CIBER ENFERMEDADES RARAS (CIBERER). Grupo 765. (2016-2020)

PI14/01956. Nuevos Mecanismos De Regulación De La Reactividad Plaquetaria En Neonatos.. Instituto de Salud Carlos III. (2015-2018)

Nuevos mecanismos de regulación de la reactividad plaquetaria en neonatos. (PI14/01956). Instituto de Salud Carlos III. (2015-2018)

Estrategia multimarcador como herramienta pronóstica en la fibrilación auricular no valvular bajo tratamiento anticoagulante oral.. Instituto de Salud Carlos III. (2012-2013)

Identificación y caracterización de nuevos determinantes genéticos reguladores de la función y número de plaquetas, relevancia en patología trombótica y hemorrágica y transtornos mieloproliferativos.. Instituto de Salud Carlos III.. (2011-2013)